Drug Trial Radar · NCT05163847
Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults
Last checked: Nov 19, 2026Latest source record: Nov 14, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
303
Actual
Start
Jun 14, 2022
Primary completion
Nov 3, 2022
Study completion Nov 3, 2022
Sponsor
- Lead sponsor
- FluGen IncIndustry
- Sponsor type
- Industry
- Collaborators
- United States Department of Defense
- First posted
- Dec 20, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 65 years, up to 85 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, double-dummy, placebo-controlled Phase 1b study evaluating the safety and immunogenicity of the investigational Cam2020 M2SR H3N2 influenza vaccine delivered IN alone or concomitantly with inactivated influenza vaccine (IIV) delivered IM to a healthy adult population age 65 to 85 years at time of enrollment.
Conditions
- Influenza Vaccine
Interventions
Cam2020 M2SR H3N2 influenza vaccineBiological
Administered intranasally on Day 1
Fluzone HD IIVBiological
Administered intramuscularly on Day 1
IN PlaceboOther
Administered intranasally on Day 1
IM PlaceboOther
Administered intramuscularly on Day 1
Primary outcomes
What the sponsor says the trial is designed to measure.
- Solicited AEs during 7 days after experimental treatmentTime frame: Day 1 to Day 8
- Unsolicited AEs during 28 days after experimental treatmentTime frame: Day 1 to Day 29
- SAEs through 28 days after experimental treatmentTime frame: Day 1 to Day 29
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
United Medical Research
Port Orange, Florida
Velocity Clinical Research
Meridian, Idaho
Johnson County Clin Trials
Lenexa, Kansas
Rochester Clinical Research
Rochester, New York
Velocity Clinical Research
Beechwood, Ohio
Velocity Clinical Research
Cedar Park, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.